Rutinib 5mg tablet

Description

Rutinib 5 mg is an oral medication containing Ruxolitinib (as ruxolitinib phosphate),

which is a kinase inhibitor used Rutinib 5 mg ONLINE for treating specific bone marrow and blood disorders.

It is commonly used to treat Rutinib 5 mg PRICE intermediate or high-risk myelofibrosis, polycythemia vera, Rutinib 5 mg IN PAKISTAN and graft-versus-host disease.

MyelofibrosisTreatment for intermediate or high-risk bone marrow cancer Polycythemia Vera (PV).

Management of a blood cancer characterized by excess production of red blood cells (to patients who fail to respond to hydr oxyurea).Graft-Versus-Host Disease (GVHD): Management of steroid refractory acute GVHD in adults and in pediatric patients who are more than 12 years old.Important Information about.

Oral administration with/without food intake. Take it intact with water and should not be chewed or crushed.Starting Dose: Dosing is individualized according to your hemoglobin and platelet counts.

This tablet can be used as the initial dose in patients who have very low platelet counts or in treating GVHDrutinib Warnings & Precautions Do not abruptly discontinue taking this drug. Withdrawal symptoms may develop like symptom flares, enlargement of spleen, and hemo dynamic instability.Risk of infection.

Taking this medication will lower your number of white blood cells, making you more vulnerable to acquiring severe infections such as bacteria, virus, and fungus.Blood counts: Anemia and thrombolytic are common side effects which requires blood tests monitoring.Severe side effects: Anemia or low platelets Diarrhea, flatulence, or nausea Headaches, dizziness, or fatigue Weight gain or edema.